Taiwan May End Free HIV/AIDS Medication To Trim CDC Budget Shortfall
This article was originally published in PharmAsia News
Taiwan may end a decade-long program of providing free AIDS drugs, citing rising costs as life expectancy grows.
You may also be interested in...
HONG KONG - Pharmacies and hospitals in the Philippines had until Tuesday to halve prices of a range of drugs or face the wrath of regulators keen to lower drug prices
Regulators from Japan and Taiwan met in late December to review prospects for convergence and pointed to manufacturing and new drug approvals as areas that were ripe for harmonization agreements.
Following an agreement by six multinational firms – including GlaxoSmithKline and AbbVie – to cut prices for antiretrovirals, Taiwan’s Centers for Disease Control is looking to import generic drugs for its free HIV drug reimbursement program, which has met with success only to see costs explode.